Glaxosmithkline Regulatory News (GSK)

1

Receive and adopt the 2023 Annual Report

3,026,657,634

99.93

1,985,899

0.07

3,028,643,533

11,560,313

2

Approve the Annual report on remuneration 

2,782,337,600

92.70

219,140,461

7.30

3,001,478,061

38,693,019

3

Election of Wendy Becker

2,908,153,080

95.87

125,392,399

4.13

3,033,545,479

6,609,293

4

Election od Dr Jeannie Lee

3,029,569,885

99.87

4,058,143

0.13

3,033,628,028

6,567,803

5

Re-election of Sir Jonathan Symonds

3,018,694,064

99.51

14,982,162

0.49

3,033,676,226

6,516,614

6

Re-election of Dame Emma Walmsley

3,028,232,685

99.81

5,822,706

0.19

3,034,055,391

6,142,099

7

Re-election of Julie Brown

3,024,167,039

99.68

9,628,961

0.32

3,033,796,000

6,386,918

8

Re-election of Elizabeth McKee Anderson

2,960,185,482

97.57

73,605,787

2.43

3,033,791,269

6,404,117

9

Re-election of Charles Bancroft

3,019,529,985

99.54

13,986,857

0.46

3,033,516,842

6,668,927

10

Re-election of Dr Hal Barron

3,022,032,114

99.61

11,790,927

0.39

3,033,823,041

6,360,307

11

Re-election of Dr Anne Beal

3,021,808,961

99.60

12,038,342

0.40

3,033,847,303

6,336,638

12

Re-election of Dr Harry C Dietz

3,029,031,724

99.85

4,650,326

0.15

3,033,682,050

6,508,974

13

Re-election of Dr Jesse Goodman

3,028,663,561

99.84

4,930,361

0.16

3,033,593,922

6,598,956

14

Re-election of Dr Vishal Sikka

2,868,354,507

94.57

164,801,089

5.43

3,033,155,596

7,017,053

15

Re-appointment of the auditor

3,014,623,759

99.95

1,608,077

0.05

3,016,231,836

23,950,717

16

Remuneration of the auditor

3,031,902,105

99.92

2,552,472

0.08

3,034,454,577

5,710,703

17

Authority for the company to make donations to political organisations and incur political expenditure

2,932,886,023

98.76

36,920,830

1.24

2,969,806,853

70,418,813

18

Authority to allot shares

2,902,088,897

95.68

130,945,918

4.32

3,033,034,815

7,163,455

19

Disapplication of pre-emption rights - general power(4)

2,961,493,840

97.71

69,555,193

2.29

3,031,049,033

9,105,429

20

Disapplication of pre-emption rights - in connection with an acquisition or specified capital investment(4)

2,937,510,909

96.91

93,802,022

3.09

3,031,312,931

8,843,231

21

Authority for the company to purchase its own shares(4)

3,007,905,874

99.25

22,735,155

0.75

3,030,641,029

9,526,430

22

Exemption from statement of senior statutory auditor's name

2,960,435,195

99.72

8,381,561

0.28

2,968,816,756

71,372,939

23

Authority for reduced notice of a general meeting other than an AGM(4)

2,795,236,350

93.79

185,233,215

6.21

2,980,469,565

59,729,307